ES548791A0 - Un procedimiento para preparar una sal de metal alcalino o alcalino-terreo de 5-cianopiridin-2-diazohidroxido - Google Patents

Un procedimiento para preparar una sal de metal alcalino o alcalino-terreo de 5-cianopiridin-2-diazohidroxido

Info

Publication number
ES548791A0
ES548791A0 ES548791A ES548791A ES548791A0 ES 548791 A0 ES548791 A0 ES 548791A0 ES 548791 A ES548791 A ES 548791A ES 548791 A ES548791 A ES 548791A ES 548791 A0 ES548791 A0 ES 548791A0
Authority
ES
Spain
Prior art keywords
alkaline
diazohidroxide
cyanopyridin
terrain
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548791A
Other languages
English (en)
Other versions
ES8700238A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alabama UA
Original Assignee
University of Alabama UA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alabama UA filed Critical University of Alabama UA
Publication of ES548791A0 publication Critical patent/ES548791A0/es
Publication of ES8700238A1 publication Critical patent/ES8700238A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES548791A 1984-11-13 1985-11-12 Un procedimiento para preparar una sal de metal alcalino o alcalino-terreo de 5-cianopiridin-2-diazohidroxido Expired ES8700238A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/670,203 US4636564A (en) 1984-11-13 1984-11-13 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use

Publications (2)

Publication Number Publication Date
ES548791A0 true ES548791A0 (es) 1986-10-01
ES8700238A1 ES8700238A1 (es) 1986-10-01

Family

ID=24689433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548791A Expired ES8700238A1 (es) 1984-11-13 1985-11-12 Un procedimiento para preparar una sal de metal alcalino o alcalino-terreo de 5-cianopiridin-2-diazohidroxido

Country Status (10)

Country Link
US (1) US4636564A (es)
EP (1) EP0181636B1 (es)
JP (1) JPS61158967A (es)
AT (1) ATE50566T1 (es)
AU (1) AU576914B2 (es)
CA (1) CA1255654A (es)
DE (1) DE3576154D1 (es)
DK (1) DK159847C (es)
ES (1) ES8700238A1 (es)
ZA (1) ZA858315B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816468A (en) * 1984-11-13 1989-03-28 The University Of Alabama 5-cyanopyridine-2-diazohydroxide, basic salts and use
DE4301109A1 (de) * 1993-01-18 1994-07-21 Bayer Ag Verfahren zur Herstellung von 6-Amino-nicotinsäurenitrilen
ITMI20011495A1 (it) * 2001-07-12 2003-01-12 Pharmaproducts Uk Ltd Sali di calcio ad attivita' citotossica
CN107602456B (zh) * 2017-10-19 2021-04-06 北京印刷学院 偶氮吡啶盐化合物及制备方法

Also Published As

Publication number Publication date
DK514285A (da) 1986-05-14
EP0181636B1 (en) 1990-02-28
JPS61158967A (ja) 1986-07-18
ZA858315B (en) 1986-10-29
ES8700238A1 (es) 1986-10-01
JPH0146511B2 (es) 1989-10-09
ATE50566T1 (de) 1990-03-15
AU576914B2 (en) 1988-09-08
CA1255654A (en) 1989-06-13
DK159847B (da) 1990-12-17
DK159847C (da) 1991-05-13
EP0181636A3 (en) 1987-04-01
AU4983585A (en) 1986-05-22
DE3576154D1 (de) 1990-04-05
US4636564A (en) 1987-01-13
DK514285D0 (da) 1985-11-07
EP0181636A2 (en) 1986-05-21

Similar Documents

Publication Publication Date Title
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
EP0460062A4 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
ES548791A0 (es) Un procedimiento para preparar una sal de metal alcalino o alcalino-terreo de 5-cianopiridin-2-diazohidroxido
ES8200678A1 (es) Un procedimiento para la produccion de 10-(4-piperidinil)-10, 11-dihidro-dibenzo b,f 1,4 oxarepinas; tiazepinas y diaze-pinas.
ES8705463A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihi- droorotil-histidil-prolinamida
ES548790A0 (es) Un procedimiento para preparar diazohidroxidos de pirazina.
ES8601200A1 (es) Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida
EP0349589A4 (en) PHARMACOLOGICALLY ACTIVE CHOLINERGE PREPARATIONS AND METHOD FOR THE PRODUCTION AND THEIR USE FOR TREATING DISEASES.
IT8419390A0 (it) Nuovi derivati dell'alfa-amino-gamma-butirrolattone, metodo per prepararli e composizioni farmaceutiche che licontengono.
MY100083A (en) Diazepinoindoles, their production and pharmaceutical compositions containing them.
ES8605261A1 (es) Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas.
ES8202561A1 (es) Un procedimiento para la produccion de 11,12-carbonato de eritromicilamina
ES8400397A1 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
ES2039436T3 (es) Un procedimiento para preparar una composicion farmaceutica.
MY102682A (en) Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds
EP0153755A3 (en) Compounds for treating hypertension
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
ES8401483A1 (es) Procedimiento para preparar nuevas furobenzazepinas.
ATE95062T1 (de) Zusammensetzung zur behandlung von krebs, gekennzeichnet durch ueberexpression des c-fmsproto-onkogens.
RU93055681A (ru) Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях
IT8448711A1 (it) Composti 1,2,4 - triazolici procedimento per produrli e composizioni farmaceutiche che li contengono.
RU93055680A (ru) Ингибиторы вич-протеазы, способ получения, их использование, композиция
IT1207990B (it) Attivita' analgesica, processo per derivati metil-piperazinici edla loro preparazione e composizioni terapeutiche che li contengono.